Patents by Inventor Philip Mark Jackson

Philip Mark Jackson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR PREPARATION OF ERIBULIN AND INTERMEDIATES THEREOF
    Publication number: 20210340156
    Abstract: The present application relate to crystalline azide compound of formula (II) which is used as an intermediate for the preparation of halichondrin B analogues such as eribulin or pharmaceutically acceptable salts thereof. The present application also covers purification process of azide compound of formula (II) and its further conversion to eribulin or a pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: October 4, 2019
    Publication date: November 4, 2021
    Inventors: Graham Andrew MEEK, Philip Mark JACKSON, Thomas MAHONEY, Pieter David DE KONING, Robert Wen Ming DAVIDSON, Christopher James COBLEY, David Andrew CHAPLIN, Helen SAMUEL, Achanta SRINIVAS, Kurella SRINIVAS, Madaraboina MAHENDER
  • PURIFICATION PROCESS FOR PREPARATION OF ERIBULIN AND INTERMEDIATES THEREOF
    Publication number: 20210260023
    Abstract: The present application relate to a purification process for preparation of halichondrin B analogues such as eribulin or pharmaceutically acceptable salts thereof having less than 0.15% or substantially free or free from one or more impurities. The present application also provide acid addition salts of eribulin and process for preparation thereof.
    Type: Application
    Filed: July 19, 2019
    Publication date: August 26, 2021
    Inventors: Thomas MAHONEY, Pieter David DE KONING, Graham ANDREW MEEK, Srinivas ACHANTA, Rajeev Rehani BUDHDEV, Philip Mark JACKSON, Srinivas ORUGANTI, Lokeswara Rao MADIVADA
  • Novel intermediate for the synthesis of prostaglandins
    Publication number: 20030004368
    Abstract: An enantiomerically enriched compound of formula 1, 1
    Type: Application
    Filed: August 19, 2002
    Publication date: January 2, 2003
    Inventors: Philip Mark Jackson, Ian Campbell Lennon
  • Intermediate for the synthesis of prostaglandins
    Patent number: 6437152
    Abstract: An enantiomerically enriched compound of formula 1, wherein Ar is phenyl optionally substituted with one or more groups selected from haloalkyl, alkyl and halide. This compound can be isolated in crystalline form, and used in the preparation of (+)-16-[3-trifluoromethyl)phenoxy]-17,18,19,20-tetranor PGF2&agr; isopropyl ester.
    Type: Grant
    Filed: July 3, 2001
    Date of Patent: August 20, 2002
    Assignee: Chirotech Technology, Inc.
    Inventors: Philip Mark Jackson, Ian Campbell Lennon
  • Novel intermediate for the synthesis of prostaglandins
    Publication number: 20020111499
    Abstract: An enantiomerically enriched compound of formula 1, 1
    Type: Application
    Filed: July 3, 2001
    Publication date: August 15, 2002
    Inventors: Philip Mark Jackson, Ian Campbell Lennon
  • Intermediate for the synthesis of prostaglandins
    Patent number: 6294679
    Abstract: An enantiomerically enriched compound of formula 1, wherein Ar is phenyl optionally substituted with one or more groups selected from haloalkyl, alkyl and halide. This compound can be isolated in crystalline form, and used in the preparation of (+)-16 [3-trifluoromethyl)phenoxy]-17,18,19,20-tetranor PGF2&agr; isopropyl ester.
    Type: Grant
    Filed: April 12, 2000
    Date of Patent: September 25, 2001
    Assignee: Chirotech Technology Limited
    Inventors: Philip Mark Jackson, Ian Campbell Lennon